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A B S T R A C T
Background: Oxidized derivatives of polyunsaturated fatty acids, collectively known as oxylipins, are labile
bioactive mediators with diverse roles in human physiology and pathology. Oxylipins are increasingly being
measured in plasma collected in clinical studies to investigate biological mechanisms and as pharmacodynamic
biomarkers for nutrient-based and drug-based interventions. Whole blood is generally stored either on ice or at
room temperature prior to processing. However, the potential impacts of delays in processing, and of tem-
perature prior to processing, on oxylipin concentrations are incompletely understood.
Objective: To evaluate the eﬀects of delayed processing of blood samples in a timeframe that is typical of a
clinical laboratory setting, using typical storage temperatures, on concentrations of representative unesteriﬁed
oxylipins measured by liquid chromatography-tandem mass spectrometry.
Design: Whole blood (drawn on three separate occasions from a single person) was collected into 5mL purple-
top potassium-EDTA tubes and stored for 0, 10, 20, 30, 60 or 120 min at room temperature or on wet ice,
followed by centrifugation at 4 °C for 10 min with plasma collection. Each sample was run in duplicate, therefore
there were six tubes and up to six data points at each time point for each oxylipin at each condition (ice/room
temperature). Representative oxylipins derived from arachidonic acid, docosahexaenoic acid, and linoleic acid
were quantiﬁed by liquid chromatography tandem mass spectrometry. Longitudinal models were used to esti-
mate diﬀerences between temperature groups 2 h after blood draw.
Results: We found that most oxylipins measured in human plasma in traditional potassium-EDTA tubes are
reasonably stable when stored on ice for up to 2 h prior to processing, with little evidence of auto-oxidation in
either condition. By contrast, in whole blood stored at room temperature, substantial time-dependent increases
in the 12-lipoxygenase-derived (12-HETE, 14-HDHA) and platelet-derived (thromboxane B2) oxylipins were
observed.
Conclusion: These ﬁndings suggest that certain plasma oxylipins can be measured with reasonable accuracy
despite delayed processing for up to 2 h when blood is stored on ice prior to centrifugation. 12-Lipoxygenase-
and platelet-derived oxylipins may be particularly sensitive to post-collection artifact with delayed processing at
room temperature. Future studies are needed to determine impacts of duration and temperature of centrifuga-
tion on oxylipin concentrations.
1. Introduction
Oxidized derivatives of 18, 20, and 22 carbon polyunsaturated fatty
acids, collectively known as oxylipins, are increasingly recognized as
bioactive mediators with diverse roles in human physiology and pa-
thology [1–3]. Oxylipins can be divided into three general functional
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classes: (1) autacoids are labile signaling molecules that act locally and
are rapidly inactivated or degraded; (2) pathway precursors are inter-
mediates in the biosynthetic pathway leading to generation of more
labile, bioactive autacoids; and (3) inactivation products are down-
stream metabolic derivatives that are often more stable than their au-
tacoid precursors [4]. Oxylipins in these three categories are increas-
ingly being measured in plasma collected in clinical studies to
investigate biochemical mechanisms mediating disease [5–8], and to
assess for pharmacodynamic biomarkers of nutrient-based and drug-
based [9–11] interventions.
Ideally, plasma oxylipin measurements provide an accurate re-
presentation of in vivo intravascular levels. However, the labile nature
of oxylipins and related compounds presents unique challenges for
accurate identiﬁcation, quantitation, and interpretation of concentra-
tions in human plasma and other tissues [12–15]. There is potential to
generate artifact during each step of collection, transport, pre-proces-
sing delay, processing, storage, and/or analysis due to: (1) degradation,
inactivation, or metabolic conversion, and (2) enzymatic and/or non-
enzymatic biosynthesis from precursor fatty acids present in the spe-
cimen. The potential for post-collection oxidation may be especially
pronounced in polyunsaturated fatty acids containing multiple 1,4-
cis,cis-pentadiene structures, such as arachidonic acid (AA) and doc-
osahexaenoic acid (DHA) (Fig. 1).
Post-collection artifact could likely be minimized by centrifuging
immediately after the collection of whole blood, followed by immediate
pipetting, and storing at −80°C until analysis. Ideally, the storage
duration will not be excessive and will be uniform among all samples.
However, this ideal approach can be challenging to achieve in a clinical
setting, where logistical factors often lead to substantial delays before
processing and variations in the duration of storage at −80°C before
analysis. Following collection, whole blood can be cooled or main-
tained at room temperature prior to processing, sometimes for periods
of several hours. Furthermore, details regarding the time interval be-
tween sample collection and processing are rarely reported in manu-
scripts or discussed as a limitation in papers.
The goal of this pilot project is to evaluate the eﬀects of delayed
processing of blood samples in a timeframe that is typical of a clinical
setting, using a range of storage temperatures, on concentrations of
representative oxylipins, pathway precursors, and inactivation products
measured by liquid chromatography tandem mass spectrometry
(LC–MS/MS).
2. Methods
The study compares plasma levels of oxylipins in samples that were
processed immediately after collection to those that were processed
after up to 120 min of storage either on wet ice or at room temperature
prior to centrifugation. The protocol was approved by NIH (#03-AG-
N322) and written informed consent was obtained for all blood col-
lection procedures. Following an overnight fast, venipuncture of the
median cubital vein in the antecubital fossa was performed with an 18-
gage butterﬂy needle, with venous whole blood collected into 5mL
‘purple top’ potassium-EDTA (BD Medical) tubes. Whole blood was
stored for 0, 10, 20, 30, 60 or 120 min at room temperature or on wet
ice (Fig. 2), followed by centrifugation at 4 °C and 1880 g for 10 min.
Following centrifugation, plasma was carefully pipetted into an
empty tube with care taken not to disturb the buﬀy coat. The entire
experiment was repeated in three separate rounds on one subject, on
three diﬀerent dates. On each of the three experimental days, each
sample was run in duplicate, therefore there were six tubes and up to
six data points at each time point for each oxylipin at each condition
(wet ice/room temperature).
2.1. Quantitation of oxylipins in plasma
To quantify concentrations of lipid mediators in plasma, lipid ex-
tracts were puriﬁed using solid phase extraction (SPE) and quantiﬁed
using LC-–MS/MS as previously described [3]. Brieﬂy, SPE of bioactive
lipids from biological matrices was performed using Strata X cartridges
(33 u, 200mg/6mL, Phenomenex, PA). The cartridges were condi-
tioned with 6 mL of methanol, followed by 6 mL of water before
samples were extracted. Samples were washed with 6mL of 10% me-
thanol. The lipids were eluted with 6 mL of methanol into a glass tube
containing 10 μL of 30% glycerol in methanol. The eluate was evapo-
rated to dryness under a stream of nitrogen and reconstituted with
40 μL of methanol, and an aliquot (10 μL) was injected into a UPLC
(Shimadzu Scientiﬁc Instruments, Columbia, MD) system coupled with
Fig. 1. Oxidation of the 1,4-cis-cis-pentadiene
structures in polyunsaturated fatty acids. (A)
Linoleic, arachidonic and docosahexaenoic
acid contain one, three and ﬁve 1,4-cis-cis-
pentadiene structures, respectively. (B) 1,4-cis-
cis-pentadiene structures are susceptible to
enzymatic and free-radical mediated perox-
idation, forming hydroperoxy-fatty acids, and
(C) epoxy-fatty acids. Hydroperoxy-fatty acids
are intermediates in the synthesis of numerous
oxylipins.
Fig. 2. Sampling timeline used to assess temperature and time-dependent ef-
fects of delayed processing on oxylipin concentrations in human plasma.
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a Qtrap 5500 (AB SCIEX, USA) for quantitative analysis. Brieﬂy, se-
paration was performed on a ZorBAX RRHD Eclipse Plus C18 column
(100mm × 4mm; 1.8 µm) (Agilent Corporation, Palo Alto, CA) con-
sisting of (A) 12mM ammonium acetate solution and acetic acid
(100:0.02 v/v) and (B) 12mM ammonium acetate and was composed of
acetonitrile/water/acetic acid (90:10:0.02, v/v/v). The ﬂow rate was
0.5 mL/min. The column oven temperature was set at 30 °C. The elution
gradient conditions were as follows: 25–40% B from 0 to 2.0 min,
40–46% B from 2 to 8min, 46–57% B from 8 to 9min, 57–66% B from 9
to 20min, 66–76% B from 20 to 22min, 76–100% B from 22 to 27min,
held at 100% B from 27 to 33min, 100–25% B from 33.1 to 35min. The
mass spectrometer was operated in electrospray negative ionization
mode using scheduled multiple reaction monitoring (sMRM) acquiring
MRM data for each analyte within a retention time window of 90 s. The
source parameters were set as follows: ion spray voltage, −4500 V;
nebulizer gas (GS1), 65 psi; turbo-gas (GS2), 70 psi; and the turbo ion
spray source temperature (TEM), 500 °C. The analytes were quantiﬁed
using MRM, as previously described [3].
3. Data analysis
To explore and graphically depict the eﬀects of temperature and
time on oxylipin concentrations, we plotted individual data points se-
parately by temperature group, for oxylipins that were above the limit
of quantitation in at least half of the samples. The limit of quantitation
for each oxylipin was deﬁned as a signal-to-noise ratio of >5. Oxylipin
values that were below the limit of quantitation were imputed by
substituting one half of the limit of quantitation value for each re-
spective oxylipin. We hypothesized that TXB2, as a platelet derived
mediator generated from TXA2, could be particularly sensitive to blood
clotting with delayed processing. TXB2 values were above the LOQ in
only 33% of samples, and had peaks present in only 53% of samples.
Despite this, we included TXB2 in these graphs and our analysis in an
exploratory manner. We hypothesized that the diﬀerences between the
treatments would increase over time and would be highest at the 120-
minute measurement. To determine the between-group diﬀerence at
minute 120, we used longitudinal mixed models for repeated measures
controlling for the time, time by group interaction, and measurement
round.
4. Results
Temperature and time-dependent eﬀects of delayed processing on
the concentrations of sixteen oxylipins derived from AA, DHA and LA
that were above the limit of quantitation in half or more of the study
samples, plus TXB2, are shown in Figs. 3–5, respectively. Model pre-
dicted oxylipin estimates after 120 min of exposure to either wet ice or
room temperature and between-group comparisons of wet ice to room
temperature are shown in Table 1.
Fig. 3. Arachidonic acid-derived
oxylipins: Molecular pathways for
synthesis and change from baseline
by time and temperature. Panel A
shows the molecular pathways in-
volved in enzymatic and non-enzy-
matic conversion of arachidonic acid
(AA) to AA-derived oxylipins. Panel B
shows individual data points for
plasma concentrations of each of the
AA-derived oxylipin measured at
baseline and following delayed pro-
cessing of up to 120 min on wet ice or
at room temperature. Rounds with all
values below the LOQ are not in-
cluded in graphs. One half of the LOQ
was imputed for values below LOQ.
Diﬀerences between cold and room
temperature at minute 120 min are
based on longitudinal mixed models
with repeated observations control-
ling for the data collection round. P-
values: *<0.05, **<0.01,
***<0.001.
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4.1. AA-derived oxylipins
Biosynthetic pathways for production of six AA-derived oxylipins
(PGE2, 8-isoPGF2α, 5-HETE, 12-HETE, 15-HETE, TXB2) are shown in
Fig. 3A. Prostaglandin E2 and 8-isoPGF2α were below the limit of
quantitation in all samples. Since 8-isoPGF2α is generally considered to
be an auto-oxidation product in humans [19], the ﬁnding that PGE2
and 8-isoPGF2α remained below the limit of quantitation and did not
diﬀer between ice and room temperature, suggests that auto-oxidation
likely did not occur to a substantial extent in the conditions of this
study. Concentrations of 12-HETE increased substantially over time in
samples that had been stored at room temperature prior to processing
(Fig. 3A), however these eﬀects were not evident with delayed pro-
cessing on wet ice. Since 12-HETE can be synthesized by platelet-de-
rived 12-lipoxygenase, this increase suggests that alterations in platelet
activation and the coagulation cascade occurred with delayed proces-
sing at room temperature [20–23]. Concentrations of TXB2, a more
stable inactivation product of labile, bioactive platelet precursor TXA2
[4] (Fig. 3A), also increased over time in samples that had been stored
at room temperature prior to processing, however since TXB2 was
above the limit of quantitation in only 33% of samples, this ﬁnding
should be interpreted with some caution. The concentrations of the
other two measured AA-derived oxylipins biosynthesized by 5-lipox-
ygenase (5-HETE) and 15-lipoxygenase (15-HETE), did not change
substantially over time and did not diﬀer between the ice and room
temperature groups.
4.2. DHA-derived oxylipins
Biosynthetic pathways for production of ﬁve DHA-derived oxylipins
(4‑hydroxy-docohexaenoic acid (4-HDHA), 10-HDHA, 14-HDHA, 17-
HDHA and 19,20-epoxy-docosapentaenoic acid (19,20-EpDPA)) are
shown in Fig. 4A. Three of these oxylipins (4-HDHA, 10-HDHA, 19,20-
EpDPA) appeared stable over time when stored on wet ice or at room
temperature. 10-HDHA is generally considered to be an auto-oxidation
product in humans because unlike rodents, humans lack 8-lipoxygenase
Fig. 4. Docosahexaenoic acid-derived oxyli-
pins: Molecular pathways for synthesis and
change from baseline by time and temperature.
Panel A shows the molecular pathways in-
volved in enzymatic and non-enzymatic con-
version of docosahexaenoic acid (DHA) to
DHA-derived oxylipins. Panel B shows in-
dividual data points for plasma concentrations
of each of the DHA-derived oxylipin measured
at baseline and following delayed processing of
up to 120 min on wet ice or at room tem-
perature. One half of the LOQ was imputed for
values below LOQ. Diﬀerences between cold
and room temperature at minute 120 min are
based on longitudinal mixed models with re-
peated observations controlling for the data
collection round. P-values: *<0.05, **<0.01,
***<0.001.
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Fig. 5. Linoleic acid-derived oxylipins: mole-
cular pathways for synthesis and change from
baseline by time and temperature. Panel A
shows the molecular pathways involved in
enzymatic and non-enzymatic conversion of
linoleic acid (LA) to LA-derived oxylipins.
Panel B shows individual data points for
plasma concentrations of each of the DHA-de-
rived oxylipin measured at baseline and fol-
lowing delayed processing of up to 120 min on
wet ice or at room temperature. One half of the
LOQ was imputed for values below LOQ.
Diﬀerences between cold and room tempera-
ture at minute 120 min are based on long-
itudinal mixed models with repeated observa-
tions controlling for the data collection round.
P-values: *<0.05, **<0.01, ***<0.001.
Table 1
Model-predicted oxylipin estimates after 120 min of exposure to room temperature or wet ice (ng/ml).
Wet ice Room temperature Diﬀerence (Room-Wet Ice)a
Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) P-value
AA
5-HETE 0.22 (0.18, 0.26) 0.21 (0.16, 0.25) −0.01 (−0.07, 0.05) 0.69
12-HETE 0.25 (0.07, 0.43) 0.62 (0.43, 0.80) 0.37 (0.11, 0.62) 0.005
15-HETE 0.41 (0.35, 0.48) 0.36 (0.30, 0.43) −0.05 (−0.14, 0.04) 0.246
TXB2b 0.05 (0.03, 0.08) 0.10 (0.07, 0.12) 0.05 (0.01, 0.08) 0.009
DHA
4-HDHA 0.13 (0.12, 0.15) 0.11 (0.10, 0.13) −0.02 (−0.04, 0.00) 0.069
10-HDHA 0.05 (0.04, 0.06) 0.05 (0.04, 0.05) −0.00 (−0.01, 0.01) 0.466
14-HDHAb 0.07 (0.02, 0.12) 0.20 (0.14, 0.25) 0.13 (0.06, 0.20) 0.001
17-HDHAb 0.34 (0.27, 0.42) 0.33 (0.26, 0.40) −0.01 (−0.12, 0.09) 0.787
19,20-EpDPA 0.07 (0.06, 0.07) 0.07 (0.06, 0.08) 0.00 (−0.01, 0.01) 0.713
LA
9-HODE 7.86 (6.87, 8.86) 8.58 (7.59, 9.57) 0.72 (−0.68, 2.12) 0.316
13-HODE 16.66 (14.70, 18.62) 17.58 (15.63, 19.54) 0.93 (−1.85, 3.70) 0.513
9,10-EpOMEb 0.79 (0.67, 0.91) 0.72 (0.61, 0.84) −0.07 (−0.23, 0.10) 0.428
9,10-DiHOME 5.33 (4.85, 5.82) 4.83 (4.34, 5.31) −0.51 (−1.19, 0.18) 0.149
9-H-12-E-LA 0.30 (0.25, 0.35) 0.28 (0.23, 0.33) −0.02 (−0.09, 0.04) 0.479
9,10-EpOMEb 0.39 (0.14, 0.63) 0.32 (0.08, 0.57) −0.07 (−0.41, 0.28) 0.714
9,10,13-TriHOME 0.83 (0.67, 0.99) 0.92 (0.76, 1.08) 0.09 (−0.14, 0.31) 0.453
9,12,13-TriHOME 2.49 (1.86, 3.12) 2.79 (2.16, 3.41) 0.30 (−0.59, 1.18) 0.513
a Based on longitudinal mixed models for repeated measures controlling for the data collection round.
b Some observations were below the limit of quantitation (LOQ) and were imputed with ½ of the LOQ.
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[24]. Thus, the observation that plasma 10-HDHA did not change over
time or diﬀer between ice and room temperature, conﬁrms a lack of
substantial auto-oxidation in the conditions of this study. 14-HDHA, a
12-lipoxygenase generated product of DHA, increased substantially in
the room temperature samples compared to wet ice, in a similar manner
as observed for 12-HETE, suggesting that 12-lipoxygenase activation
during clotting is not speciﬁc to one substrate. 17-HDHA values varied
widely and appeared to be independent of time and temperature.
4.3. LA-derived oxylipins
Proposed biosynthetic pathways for production of eight LA-derived
oxylipins are shown in Fig. 5A. Like 12-HETE (derived from AA) and
14-HDHA (derived form DHA), 9-HODE is reported to be a 12-lipox-
ygenase derivative of LA [25]. However, unlike 12-HETE and 14-
HDHA, plasma 9-HODE concentrations were not signiﬁcantly higher
when whole blood was stored at room temperature compared to ice, for
up to 2 h. Potential explanations for this discrepancy include that 9-
HODE can be synthesized via several other enzymatic and non-enzy-
matic sources including cyclooxygenases [26,27], 12-lipoxygenase
(non-platelet), and free-radical mediated oxidation [28]. Moreover, AA
and DHA contain three and ﬁve 1,4-cis,cis-pentadiene structures re-
spectively (Fig. 1), and therefore are considered to be more susceptible
to oxidation compared to LA which contains a single 1,4-cis,cis-penta-
diene structure.
5. Discussion
Oxylipins hold promise as biomarkers for predicting diseases in
observational settings and as pharmacodynamic markers for targeting
diet or drug interventions [9,10]. Since plasma oxylipins are derived
from more abundant polyunsaturated fatty acids containing 1,4-cis,cis-
pentadiene structures that are highly susceptible to oxidation, any pre-
analytical variable that alters synthesis or degradation could potentially
create post-collection artifact in measured metabolites [12,16–18,29],
including oxylipins.
In the present study we sought to determine the eﬀect of delayed
processing of whole blood samples in a timeframe that is typical of a
clinical setting, using typical storage temperatures on concentrations of
unesteriﬁed oxylipins including pathway precursors, and inactivation
products measured by LC–MS/MS. Findings suggest that the con-
centrations of many oxylipins measured in human plasma using tradi-
tional potassium-EDTA tubes are reasonably stable when stored for up
to 2 h prior to processing, particularly when stored on wet ice, with
little evidence of auto-oxidation products in either condition. The
substantial increases observed for 12-lipoxygenase-derived (12-HETE,
14-HDHA) and platelet-derived (TXB2) oxylipins with delayed proces-
sing at room temperature indicate that these compounds may be par-
ticularly sensitive to post-collection artifact. These ﬁndings suggest that
certain plasma oxylipins can be measured with reasonable accuracy
despite delayed processing for up to 2 h following blood collection, as
long as blood is stored on ice prior to centrifugation. The pronounced
post-collection artifact in 12-lipoxygenase and platelet-derived oxyli-
pins with delayed processing at room temperature could potentially be
due to activation of clotting cascade [20,22,23].
Factors that limit the generalizability of this study include the small
sample size, non-independent samples, and the substantial number of
samples below the limits of quantitation. Experiments used standard
clinical “purple top” potassium EDTA tubes for blood collection and
therefore ﬁndings are not necessarily generalizable to blood collected
using other tubes (i.e. plasma citrate, heparin) or for serum or other
blood fractions. Use of heparin tubes has previously been reported to
markedly increase oxylipin concentrations [30]. Since serum is gener-
ated via activation of the clotting cascade, one could speculate that use
of serum separator tubes might alter the production of oxylipins derived
from platelets (e.g. 12-HETE, 14-HDHA, thromboxanes) in a similar
manner as observed with delayed processing at room temperature in
the present study, however this requires experimental conﬁrmation.
The ﬁnding that oxylipins that were below the limit of quantitation
with immediate processing were not increased with delayed processing
suggests that the oxylipins proﬁled in the present study were not syn-
thesized ex vivo. Importantly, some oxylipins have potent bioactions at
very low concentrations, and it is possible that certain labile oxylipins
were already degraded even with immediate processing. Future studies
should examine whether more rapid centrifugation (e.g. 1–2min) im-
pacts results.
5.1. Summary and conclusions
Plasma samples derived from whole blood that was kept on ice for
up to 2 h prior to centrifugation appear suitable for measuring many
oxylipins with the caveats noted above. 12-lipoxygenase and platelet-
derived oxylipins are sensitive to post-collection artifact with delayed
processing at room temperature. Results may have implications for
design, implementation, and interpretation of clinical studies mea-
suring oxylipins in plasma. Future studies are needed to determine the
impacts of other pre-analytical variables including venipuncture loca-
tion, needle gauge, blood collection tube type, duration and tempera-
ture of centrifugation, and post-processing storage conditions.
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